Europe is a significant and rapidly growing market within the Medical Tourism Market , valued at USD 7,733.00 million in 2024 and projected to grow at a CAGR of 15.88% during the forecast period. Medical tourism has grown in prominence throughout Europe as patients seek more timely and cost-effective treatments in the midst of burdened home healthcare systems and long waiting lists. The European market is characterized by patient flows both within the European Union and from outside, with countries such as Germany, France, Turkey, Lithuania, Poland, and Croatia emerging as key destinations.

In the United Kingdom, outbound medical tourism accelerated post-COVID. By 2022, around 350,000 UK residents traveled abroad for procedures such as hip replacements, knee replacements, cataracts, and cardiology, up from approximately 248,000 in 2019. This surge was driven largely by overburdened NHS waiting times. Clinics in Lithuania, Poland, Croatia, and France are increasingly catering to these patients, providing faster access at reduced costs. A Highland patient's hip replacement in Poland, for instance, cost about half as much as private care in the UK. The cost savings, combined with shorter waiting times, make cross-border care an attractive alternative for patients who can plan their treatments.

Turkey has emerged as a dominant player in the European and Middle Eastern medical tourism landscape. In 2019, Turkey treated approximately 264,000 medical tourists in the first half of the year, with forecasts aiming for a million by year-end. By 2023, the number increased to 1.8 million visitors, generating approximately USD 3.1 billion in revenue. Turkey's medical tourism sector aims to reach USD 20 billion by 2028. The country has built a strong reputation for cosmetic surgery, dental procedures, and hair transplants, leveraging its combination of affordable prices, experienced surgeons, and modern facilities. However, these gains are accompanied by safety concerns; since 2019, at least 28 British patients have died following elective treatments in Turkey, sparking increased scrutiny and calls for more international oversight.

Germany and France attract patients seeking specialized treatments, particularly in oncology, orthopedics, and rehabilitation. Switzerland and Austria are known for their luxury wellness and rehabilitation services. The European Union's Cross-Border Healthcare Directive facilitates patient movement within member states, providing a legal framework for reimbursement and quality standards. As European healthcare systems continue to face pressures from aging populations and resource constraints, cross-border healthcare is expected to become an increasingly important component of the continent's medical landscape.